Silverarc Capital Management, LLC Ayala Pharmaceuticals, Inc. Transaction History

Silverarc Capital Management, LLC

  • $402 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$8.32 - $12.45 $340,753 - $509,902
-40,956 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$8.13 - $14.09 $143,022 - $247,871
17,592 Added 75.3%
40,956 $464,000
Q2 2021

Aug 16, 2021
BUY
$9.2 - $11.3 $214,948 - $264,013
23,364 New
23,364 $238,000

Others Institutions Holding AYLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Ayala Pharmaceuticals, Inc.

AYLA Quotes by TradingView
  • Ticker AYLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,833,300
  • Description
  • Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...
More about AYLA
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email